'"`UNIQ--vote-000010F8-QINU`"' Pre-treatment screening for latent TB (PPD or IGRA) and chronic hepatitis B is standard. Anti-drug antibody formation is a recognized cause of secondary loss of response'"`UNIQ--ref-000010F9-QINU`"'.
uses
String
starting_dose
String
40 mg SC every other week (most adult indications); IBD induction 160 mg week 0, 80 mg week 2, then 40 mg every other week
preparations
String
40 mg/0.4 mL or 40 mg/0.8 mL prefilled syringe and autoinjector pen; 10, 20, 80 mg pediatric/induction strengths
fda_max
String
40 mg every week (selected indications); otherwise 40 mg every other week
pill_id
Text
routes
List of String, delimiter: ,
Subcutaneous
onset
String
Symptomatic effect within weeks; full response by 12-24 weeks
